241 related articles for article (PubMed ID: 20432761)
21. Immune reconstitution syndrome associated with parvovirus B19-induced pure red cell aplasia during highly active antiretroviral therapy.
Intalapaporn P; Poovorawan Y; Suankratay C
J Infect; 2006 Aug; 53(2):e79-82. PubMed ID: 16313965
[TBL] [Abstract][Full Text] [Related]
22. Significant decrease in hemoglobin and hematocrit levels in a virologically controlled HIV-infected patient. Pure red cell aplasia (PRCA) caused by human parvovirus B19.
Naval-Srinivas RM; Church LW
AIDS Read; 2003 Apr; 13(4):189. PubMed ID: 12741369
[No Abstract] [Full Text] [Related]
23. Pure red cell aplasia due to parvovirus B19 infection transmitted probably through hematopoietic stem cell transplantation.
Wasak-Szulkowska E; Grabarczyk P; Rzepecki P
Transpl Infect Dis; 2008 Jun; 10(3):201-5. PubMed ID: 17631000
[TBL] [Abstract][Full Text] [Related]
24. A patient with pure red cell aplasia after allogenic stem-cell transplantation. Parvo B19 infection.
Berrevoets MA; van der Post RS; Schaap N
Neth J Med; 2013 Sep; 71(7):370, 374. PubMed ID: 24038564
[No Abstract] [Full Text] [Related]
25. Severe anemia from parvovirus b19 infection in pediatric renal transplant recipients: two case reports.
Pinto V; Grandy J; Zambrano P; Corta B; Salas P; Salgado I; Santander J; Salgado C; Chadid J; Iñiguez R
Transplant Proc; 2008 Nov; 40(9):3261-4. PubMed ID: 19010248
[TBL] [Abstract][Full Text] [Related]
26. Intravenous immunoglobulin therapy for pure red cell aplasia related to human parvovirus b19 infection: a retrospective study of 10 patients and review of the literature.
Crabol Y; Terrier B; Rozenberg F; Pestre V; Legendre C; Hermine O; Montagnier-Petrissans C; Guillevin L; Mouthon L;
Clin Infect Dis; 2013 Apr; 56(7):968-77. PubMed ID: 23243178
[TBL] [Abstract][Full Text] [Related]
27. [Diagnosis of parvovirus B19 infection in hematological patients with partial red cell aplasia of the bone marrow].
Iaguzhinskaia OE; Pivnik AV; Fevraleva IS; Sudarikov AB; Lisovina IuS; Loginova IV; Shitareva IV
Ter Arkh; 2001; 73(8):50-6. PubMed ID: 11599268
[TBL] [Abstract][Full Text] [Related]
28. Incidence and clinical significance of human parvovirus B19 infection in kidney transplant recipients.
Ki CS; Kim IS; Kim JW; Lee NY; Kim SH; Lee KW; Kim SJ; Joh JW; Huh WS; Oh HY
Clin Transplant; 2005 Dec; 19(6):751-5. PubMed ID: 16313320
[TBL] [Abstract][Full Text] [Related]
29. Chronic pure red cell aplasia caused by parvovirus B19 in AIDS: use of intravenous immunoglobulin--a report of eight patients.
Koduri PR; Kumapley R; Valladares J; Teter C
Am J Hematol; 1999 May; 61(1):16-20. PubMed ID: 10331506
[TBL] [Abstract][Full Text] [Related]
30. Long-term parvovirus B19 viraemia associated with pure red cell aplasia after allogeneic bone marrow transplantation.
Plentz A; Hahn J; Holler E; Jilg W; Modrow S
J Clin Virol; 2004 Sep; 31(1):16-9. PubMed ID: 15288608
[TBL] [Abstract][Full Text] [Related]
31. Pure Red Cell Aplasia and Antibody-Mediated Rejection: Double Trouble in 1 Kidney Transplant Recipient Solved by Intravenous Immunoglobulin Infusion: A Case Report.
Knysak M; Napora M; Misiukiewicz-Poć M; Pawłowska A; Kwella N; Zbrzeźniak J; Winiarska A; Stompór T
Transplant Proc; 2020 Oct; 52(8):2530-2532. PubMed ID: 32276841
[TBL] [Abstract][Full Text] [Related]
32. Recurrence of Pure Red Cell Aplasia in a Kidney Transplant Recipient Due to Reactivation of Parvovirus B19 Infection Despite Two Cycles of Intravenous Immunoglobulin Therapy.
Kaya B; Paydas S
Exp Clin Transplant; 2019 Jan; 17(Suppl 1):195-197. PubMed ID: 30777553
[TBL] [Abstract][Full Text] [Related]
33. Dose-by-dose virological and hematological responses to intravenous immunoglobulin in an immunocompromised patient with persistent parvovirus B19 infection.
Tang JW; Lau JS; Wong SY; Cheung JL; Chan CH; Wong KF; Wong A; Chan PK
J Med Virol; 2007 Sep; 79(9):1401-5. PubMed ID: 17607784
[TBL] [Abstract][Full Text] [Related]
34. [Familial transient red cell aplasia from parvovirus B-19 infection].
Salvini F; Tonella M; Carpani G; Scaglioni S; Zuccotti GV
Pediatr Med Chir; 2002; 24(4):306-7. PubMed ID: 12197091
[TBL] [Abstract][Full Text] [Related]
35. Pure red cell aplasia caused by parvovirus B19 in two patients without chronic hemolysis.
Kaneko H; Shimura K; Nishida K; Fujiwara Y; Matsumoto Y; Kuroda J; Horiike S; Yokota S; Ohkawara Y; Taniwaki M
J Infect Chemother; 2011 Apr; 17(2):268-71. PubMed ID: 20820839
[TBL] [Abstract][Full Text] [Related]
36. Parvovirus B19 infection in an isolated pancreas transplant recipient.
Onitilo AA; Shaw GR
Transplant Proc; 2005 Dec; 37(10):4433-5. PubMed ID: 16387138
[TBL] [Abstract][Full Text] [Related]
37. Pure red cell aplasia due to parvovirus B19 infection in solid organ transplantation.
Ahsan N; Holman MJ; Gocke CD; Groff JA; Yang HC
Clin Transplant; 1997 Aug; 11(4):265-70. PubMed ID: 9267713
[TBL] [Abstract][Full Text] [Related]
38. Acute renal failure in a pediatric kidney allograft recipient treated with intravenous immunoglobulin for parvovirus B19 induced pure red cell aplasia.
Subtirelu MM; Flynn JT; Schechner RS; Pullman JM; Feuerstein D; Del Rio M
Pediatr Transplant; 2005 Dec; 9(6):801-4. PubMed ID: 16269055
[TBL] [Abstract][Full Text] [Related]
39. Pure Red Cell Aplasia Related to Parvovirus B19 Infection in Simultaneous Pancreas and Kidney Recipient: A Case Report.
Nowacka-Cieciura E; Karakulska-Prystupiuk E; Żuk-Wasek A; Lisik W; Basak GW; Durlik M
Transplant Proc; 2020 Oct; 52(8):2539-2543. PubMed ID: 32591136
[TBL] [Abstract][Full Text] [Related]
40. Successful high-titer immunoglobulin therapy for persistent parvovirus B19 infection in a lymphoma patient treated with rituximab-combined chemotherapy.
Isobe Y; Sugimoto K; Shiraki Y; Nishitani M; Koike K; Oshimi K
Am J Hematol; 2004 Dec; 77(4):370-3. PubMed ID: 15558805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
